Encompass Health CorpEHC
Price$119.06Intrinsic value$115.693% below price

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $6.2B+15.5% YoYTTM through 30 Jun 2026
Net Income $621M+36.3% YoYTTM through 30 Jun 2026
Free Cash Flow $413.4MTTM through 30 Jun 2026

Margins

Current
EBITDA Margin22.1%
Operating Margin20.3%
Net Margin10.0%

Returns

18.4%ROE
8.3%ROA
12.2%ROIC

Balance Sheet Health

Debt / Equity0.78x
Current Ratio1.17x
Net Debt$2.5B
Cash & Equivalents$107.7M

Quality Metrics

Altman Z-Score3.37
Piotroski F-Score7 / 9
FCF Margin6.7%
Rule of 4010.8
Earnings-Beat Rate100.0%

Multi-Year Trend

Revenue
'19'20'21'22'23'24'25
FY2025: $5.9B
Diluted EPS$6.14TTM
'19'20'21'22'23'24'25
FY2025: $5.54

Dividend

$0.57Per share, FY20260.46%Yield-8.5%5-yr growth

Capital Allocation

Capex Intensity12.9%
All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.